We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 671

Excessive Pricing: Aspen lose their appeal in Italy - and are in the Commission’s crosshairs
  • Bristows LLP
  • Italy
  • August 7 2017

Last year we reported the Italian’s take on excessive pricing (here), where South African pharmaceutical Aspen was in the firing line for increasing


Italy opens the door to corporate ownership of pharmacies - a revolution for the Italian Pharma distribution
  • Hogan Lovells
  • Italy
  • August 2 2017

By Law passed today, August 2nd, 2017 (Law for the improvement of the competition on the market), further to a recommendation of the Italian


“Gelli” Law - The introduction of a two paths for medical liability
  • Nctm Studio Legale
  • Italy
  • July 31 2017

The so-called "Gelli" Law (Law No. 24 of 8 March 2017), named after its main drafter, finally come into force on 1 April 2017. The new law sets the


Mela di gala
  • Bugnion SpA
  • Italy
  • July 18 2017

L’acquisto di una delle varietà di mele che colorano i banchi dei nostri supermercati è solo in apparenza un gesto banale. Esso è, in effetti


Life Sciences: product regulation and liability in Italy
  • Avvocati Associati Franzosi Dal Negro Setti
  • Global, Italy
  • July 4 2017

A structured guide to product regulation and liability laws in Italy


Pharmacovigilance in Italy
  • Avvocati Associati Franzosi Dal Negro Setti
  • Global, Italy
  • July 4 2017

A structured guide to Pharmacovigilance in Italy


Clinical trials in Italy
  • Avvocati Associati Franzosi Dal Negro Setti
  • Italy, Global
  • July 4 2017

A structured guide to clinical trials in Italy


Life Sciences: Compliance and enforcement in Italy
  • Avvocati Associati Franzosi Dal Negro Setti
  • Global, Italy
  • July 4 2017

A structured guide to compliance and dishonest practices in Italy


L'Autorità Della Concorrenza Sudafricana Avvia Indagini Nel Settore Dei Farmaci Antitumorali
  • Baker McKenzie
  • Italy, South Africa
  • June 27 2017

L'Autorità Garante della Concorrenza sudafricana pone al centro dell'attenzione il settore farmaceutico, designandolo come prioritario nell'ambito


Italian Medicines Agency warns MA holders of products imminently subject to ‘sunset clause’
  • Allen & Overy LLP
  • European Union, Italy
  • June 26 2017

Last Friday, the Italian Medicines Agency (AIFA) published a warning to marketing authorisation (MA) holders concerning the imminent invalidity of